United States & Europe EndoAVF Device Industry Poised for Steady Growth, Projected to Reach USD 118.3 Million by 2034

According to the latest analysis by Future Market Insights, the United States and Europe EndoAVF device market is set to experience robust growth over the next decade. The industry, valued at USD 85.1 million in 2024, is expected to register a steady Compound Annual Growth Rate (CAGR) of 3.3%, reaching USD 118.3 million by 2034.

The rising demand for single-catheter systems is a significant driver behind this growth, with sales anticipated to surge at a CAGR of 3.4%. Single-catheter systems have gained widespread adoption in healthcare facilities due to their simpler design and ease of use compared to dual-catheter systems. These systems enable healthcare professionals to handle and navigate endovascular procedures more efficiently, enhancing patient outcomes and procedural success rates.

Checkout Now to Access Actionable Insights

Multiple factors are set to propel demand for EndoAVF devices across the United States and Europe through 2034. These include a growing incidence of end-stage renal disease (ESRD) and an escalating preference for minimally invasive procedures like EndoAVF.

In 2018, the prevalence of ESKD was 242 per million in the United States. This figure is anticipated to increase further due to rise in diabetes, hypertension, glomerulonephritis, and cystic kidney disease, creating growth prospects for EndoAVF device industry.

Today, both patients and healthcare professionals are showing a preference for minimally invasive procedures like EndoAVF. This is due to side effects associated with conventional surgical procedures. Courtesy of this, demand for EndoAVF devices is set to grow steadily across the United States and Europe.

Key Takeaways from the Report:

  • The United States & Europe EndoAVF device industry is set to total USD 118.3 million by 2034.
  • Based on product, single-catheter system demand is forecast to rise at 4% CAGR through 2034.
  • By technology, thermal resistance held an 1% value share in 2024.
  • By end-user, the hospital segment will record a CAGR of 6% from 2024 to 2034.
  • The United States industry value is predicted to total USD 52.54 million in 2024.
  • Demand in Germany is set to grow at 2% CAGR through 2034.

“Spike in kidney diseases and growing preference for minimally invasive surgeries are anticipated to fuel growth of the EndoAVF device industry in the United States and Europe through 2034,” says a lead analyst of Future Market Insights (FMI).

Who is Winning?

Leading EndoAVF device manufacturers are focusing on new product launches and approvals to stay ahead of the competition. They are establishing new research and development facilities to develop innovative EndoAVF solutions. Various companies are employing strategies like mergers, partnerships, and distribution agreements.

Recent Developments:

  • In June 2023, BD strengthened its manufacturing ability with the inauguration of a €4 million research and development facility in Blackrock, Dublin. It also invested €30 million to strengthen its manufacturing facility in Enniscorthy, Wexford.
  • In February 2019, BD received 510(k) approval from the U.S. Food and Drug Administration for their BD WavelinQ 4 French (4F) EndoAVF system.

Unleash Strategic Potential Get the Complete Report Here

Key Companies Profiled:

  • BD
  • Medtronic Plc

Industry Segmentation:

By Product:

  • Single-catheter system
  • Dual-catheter system

By Technology:

  • Thermal Resistance
  • Radiofrequency Pulse

By End-user:

  • Hospitals
  • Ambulatory Surgical Centers
  • Dialysis Centers

By Country:

  • United States
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Leave a comment

Your email address will not be published. Required fields are marked *